Literature DB >> 26224364

Severe Influenza in 33 US Hospitals, 2013-2014: Complications and Risk Factors for Death in 507 Patients.

Nirav S Shah1, Jared A Greenberg1, Moira C McNulty1, Kevin S Gregg2, James Riddell2, Julie E Mangino3, Devin M Weber3, Courtney L Hebert3, Natalie S Marzec4, Michelle A Barron4, Fredy Chaparro-Rojas5, Alejandro Restrepo6, Vagish Hemmige6, Kunatum Prasidthrathsint7, Sandra Cobb7, Loreen Herwaldt7, Vanessa Raabe8, Christopher R Cannavino8, Andrea Green Hines9, Sara H Bares9, Philip B Antiporta10, Tonya Scardina11, Ursula Patel12, Gail Reid10, Parvin Mohazabnia13, Suresh Kachhdiya13, Binh-Minh Le13, Connie J Park14, Belinda Ostrowsky14, Ari Robicsek1, Becky A Smith15, Jeanmarie Schied16, Micah M Bhatti16, Stockton Mayer17, Monica Sikka17, Ivette Murphy-Aguilu17, Priti Patwari18, Shira R Abeles19, Francesca J Torriani19, Zainab Abbas20, Sophie Toya20, Katherine Doktor21, Anindita Chakrabarti21, Susanne Doblecki-Lewis21, David J Looney22, Michael Z David1.   

Abstract

BACKGROUND: Influenza A (H1N1) pdm09 became the predominant circulating strain in the United States during the 2013-2014 influenza season. Little is known about the epidemiology of severe influenza during this season.
METHODS: A retrospective cohort study of severely ill patients with influenza infection in intensive care units in 33 US hospitals from September 1, 2013, through April 1, 2014, was conducted to determine risk factors for mortality present on intensive care unit admission and to describe patient characteristics, spectrum of disease, management, and outcomes.
RESULTS: A total of 444 adults and 63 children were admitted to an intensive care unit in a study hospital; 93 adults (20.9%) and 4 children (6.3%) died. By logistic regression analysis, the following factors were significantly associated with mortality among adult patients: older age (>65 years, odds ratio, 3.1 [95% CI, 1.4-6.9], P=.006 and 50-64 years, 2.5 [1.3-4.9], P=.007; reference age 18-49 years), male sex (1.9 [1.1-3.3], P=.031), history of malignant tumor with chemotherapy administered within the prior 6 months (12.1 [3.9-37.0], P<.001), and a higher Sequential Organ Failure Assessment score (for each increase by 1 in score, 1.3 [1.2-1.4], P<.001).
CONCLUSION: Risk factors for death among US patients with severe influenza during the 2013-2014 season, when influenza A (H1N1) pdm09 was the predominant circulating strain type, shifted in the first postpandemic season in which it predominated toward those of a more typical epidemic influenza season.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26224364     DOI: 10.1017/ice.2015.170

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  20 in total

1.  Surveillance Data for Eight Consecutive Influenza Seasons in Sicily, Italy.

Authors:  Fabio Tramuto; Vincenzo Restivo; Claudio Costantino; Giuseppina Maria Elena Colomba; Carmelo Massimo Maida; Alessandra Casuccio; Francesco Vitale
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

2.  Behavior of nurses and nurse aides toward influenza vaccine: the impact of the perception of occupational working conditions.

Authors:  Alexandre Mignot; Marie-Claire Wilhelm; Annick Valette; Marie-Laure Gavard-Perret; Emmanuel Abord-De-Chatillon; Olivier Epaulard
Journal:  Hum Vaccin Immunother       Date:  2019-12-06       Impact factor: 3.452

3.  Rates of Severe Influenza-Associated Outcomes Among Older Adults Living With Diabetes-Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012-2017.

Authors:  Daniel Owusu; Melissa A Rolfes; Carmen S Arriola; Pam Daily Kirley; Nisha B Alden; James Meek; Evan J Anderson; Maya L Monroe; Sue Kim; Ruth Lynfield; Kathy Angeles; Nancy Spina; Christina B Felsen; Laurie Billing; Ann Thomas; H Keipp Talbot; William Schaffner; Ryan Chatelain; Carrie Reed; Shikha Garg
Journal:  Open Forum Infect Dis       Date:  2022-03-16       Impact factor: 4.423

4.  Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivo.

Authors:  Sweety Samal; Tripti Shrivastava; Praveen Sonkusre; Zaigham Abbas Rizvi; Rajesh Kumar; Shubbir Ahmed; Preeti Vishwakarma; Naveen Yadav; Manish Bansal; Kanchana Chauhan; Sebanta Pokhrel; Supratik Das; Padmakar Tambare; Amit Awasthi
Journal:  J Biol Chem       Date:  2020-08-13       Impact factor: 5.157

5.  Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).

Authors:  Shekhar Ghamande; Courtney Shaver; Kempapura Murthy; Chandni Raiyani; Heath D White; Tasnim Lat; Alejandro C Arroliga; Dayna Wyatt; H Keipp Talbot; Emily T Martin; Arnold S Monto; Richard K Zimmerman; Donald B Middleton; Fernanda P Silveira; Jill M Ferdinands; Manish M Patel; Manjusha Gaglani
Journal:  Clin Infect Dis       Date:  2022-04-28       Impact factor: 20.999

6.  Effectiveness of antiviral treatment in preventing death in severe hospitalised influenza cases over six seasons.

Authors:  A Domínguez; A Romero-Tamarit; N Soldevila; P Godoy; M Jané; A Martínez; N Torner; J A Caylà; C Rius
Journal:  Epidemiol Infect       Date:  2018-04-02       Impact factor: 4.434

7.  Influenza virus infections among patients attending emergency department according to main reason to presenting to ED: A 3-year prospective observational study during seasonal epidemic periods.

Authors:  Enrique Casalino; Stephanie Antoniol; Nadhira Fidouh; Christophe Choquet; Jean-Christophe Lucet; Xavier Duval; Benoit Visseaux; Laurent Pereira
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

8.  Descriptive study of severe hospitalized cases of laboratory-confirmed influenza during five epidemic seasons (2010-2015).

Authors:  Núria Torner; Ana Martínez; Luca Basile; MMar Mosquera; Andrés Antón; Cristina Rius; M Rosa Sala; Sofia Minguell; Elsa Plasencia; Mónica Carol; Pere Godoy; Núria Follia; Irene Barrabeig; M Angeles Marcos; Tomàs Pumarola; Mireia Jané
Journal:  BMC Res Notes       Date:  2018-04-14

9.  Patient's behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient's influenza vaccine uptake.

Authors:  Enrique Casalino; Aiham Ghazali; Donia Bouzid; Stephanie Antoniol; Laurent Pereira; Philippe Kenway; Christophe Choquet
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

10.  ICU-treated influenza A(H1N1) pdm09 infections more severe post pandemic than during 2009 pandemic: a retrospective analysis.

Authors:  Pekka Ylipalosaari; Tero I Ala-Kokko; Jouko Laurila; Lauri Ahvenjärvi; Hannu Syrjälä
Journal:  BMC Infect Dis       Date:  2017-11-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.